| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities: | ||||||||||
Net income | ||||||||||
1,332 | 1,771 | 1,924 | 1,872 | 1,110 | 592 | 0 | 0 | 0 | - | - |
Net loss | ||||||||||
- | - | - | - | - | - | - | - | - | - | 0 |
Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||||||||
Deferred tax liabilities | ||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - |
Interest earned on investments and marketable securities held in Trust Account | ||||||||||
-3,177 | -3,473 | 0 | 0 | 0 | - | - | - | - | - | 0 |
Changes in operating assets and liabilities: | ||||||||||
Prepaid expenses | ||||||||||
20 | 260 | 0 | 0 | 0 | - | - | - | - | - | 0 |
Accounts payable | ||||||||||
175 | 13 | 55 | 81 | 104 | 14 | -27 | -5 | 0 | 0 | 0 |
Accrued expenses | ||||||||||
10 | 24 | -139 | -112 | 25 | -7 | 145 | 122 | 0 | 0 | 0 |
Franchise tax payable | ||||||||||
-0 | 160 | 0 | 0 | 0 | - | - | - | - | - | - |
Deferred tax liability | ||||||||||
- | - | - | - | - | - | - | - | - | - | 0 |
Net cash used in operating activities | ||||||||||
-1,839 | -1,957 | -1,809 | -1,746 | -1,218 | -931 | -740 | -355 | 0 | 0 | 0 |
Cash Flows from Investing Activities | ||||||||||
Principal deposited in Trust Account | ||||||||||
- | - | - | - | - | - | - | - | - | - | 0 |
Interest released from Trust Account | ||||||||||
-1,011 | -1,171 | 0 | 0 | 0 | - | - | - | - | - | 0 |
Net cash provided by investing activities | ||||||||||
1,011 | 1,171 | 0 | 0 | 0 | - | - | - | - | - | 0 |
Cash Flows from Financing Activities: | ||||||||||
Proceeds from note payable to related parties | ||||||||||
780 | 750 | 750 | 400 | 560 | 260 | 460 | 460 | 0 | 0 | 0 |
Repayment of note payable to related parties | ||||||||||
- | - | - | - | - | - | - | - | - | - | 0 |
Proceeds received from initial public offering | ||||||||||
- | - | - | - | - | - | - | - | - | - | 0 |
Offering costs | ||||||||||
- | - | - | - | - | 3,671 | 3,740 | 3,417 | 0 | 0 | 0 |
Proceeds received from private placement | ||||||||||
- | - | - | - | - | - | - | - | - | - | 0 |
Issuance of Class B common stock to Sponsor, shares | ||||||||||
- | - | - | - | - | - | - | - | - | 25 | 25 |
Net cash provided by financing activities | ||||||||||
780 | 750 | 695 | 23 | 159,478 | 159,138 | 159,269 | 159,617 | 0 | 0 | 0 |
Net increase in cash and cash equivalents | ||||||||||
-47 | -35 | -57 | -727 | 429 | 177 | 363 | 907 | 0 | 0 | 0 |
Supplemental disclosure of noncash investing and financing activities: | ||||||||||
Offering costs included in accounts payable | ||||||||||
- | - | - | - | - | 67 | 91 | 318 | 0 | 0 | 0 |
Offering costs included in accrued expenses | ||||||||||
- | - | - | - | - | - | - | 45 | 0 | 0 | 0 |
Deferred underwriting commissions in connection with the initial public offering | ||||||||||
- | - | - | - | - | - | - | - | - | - | 0 |
Reclassification of deferred offering costs to paid-in capital | ||||||||||
- | - | - | - | - | - | - | - | - | - | 0 |
Change in value of Class A common stock subject to possible redemption | ||||||||||
1,332 | 1,771 | 0 | 0 | 0 | - | - | - | - | - | 0 |